Cytokinetics, Incorporated CYTK announced that the European Commission (EC) has approved Myqorzo (aficamten), 5 mg, 10 mg, 15 mg and 20 mg tablets, for the treatment of adult patients with symptomatic ...
An experimental Ventyx Biosciences drug led to statistically significant reductions in blood levels of a protein that’s an indicator of cardiovascular risk, preliminary Phase 2 results that support ...
Cardiac patients who need life-saving surgical treatment can be heartened by the technological advances that let them live ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results